News
Eli Lilly stock down 19% in May, on track for worst month since 2009. But June historically brings better fortune, with 67% ...
Eli Lilly's growth is impressive, but its current valuation is only justifiable with sustained high growth. Click here to ...
After a fourth quarter in which revenue boomed throughout the biopharma industry, there were reversals for several drugmakers ...
Zacks Investment Research on MSN15h
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should KnowEli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of ...
"We are introducing Wegovy (injectable Semaglutide 2.4 mg) this year, which offers full therapeutic strengths of semaglutide ...
Algernon to Acquire NoBrainer - Plans to Establish Alzheimer's Diagnostic and Treatment Medical Clinics Featuring New PET Scan Technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback